Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Rivastigmine 4.6mg/24hours transdermal patches Rivastigmine 9.5mg/24hours transdermal patches MSN/2025/062 Tier 3 – high impact Date of issue: 03/12/2025 Summary Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches are in limited supply until w/c 15 December 2025. Rivastigmine 13.3mg/24hours transdermal [...]
The post Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches appeared first on Community Pharmacy England.
Recent Comments